{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:14:24Z","timestamp":1792678464156,"version":"4.5.0"},"reference-count":147,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00087","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T23:43:14Z","timestamp":1489707794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge\u2013Weber Syndrome"],"prefix":"10.3389","volume":"8","author":[{"given":"Carl E.","family":"Stafstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Staedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"486402","DOI":"10.1155\/2012\/486402","article-title":"Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders","volume":"2012","author":"Gipson","year":"2012","journal-title":"Neural Plast"},{"issue":"7","key":"B2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"B3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1871527315666160413120638","article-title":"mTOR, a potential target to treat autism spectrum disorder","volume":"15","author":"Sato","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/9781118456989.ch1","article-title":"Recognizing seizures and epilepsy: insights from pathophysiology","volume-title":"Epilepsy","author":"Stafstrom","year":"2014"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8607038","DOI":"10.1155\/2016\/8607038","article-title":"Plasticity of hippocampal excitatory-inhibitory balance: missing the synaptic control in the epileptic brain","volume":"2016","author":"Bonansco","year":"2016","journal-title":"Neural Plast"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-444-62702-5.00006-8","article-title":"Tuberous sclerosis complex","volume":"132","author":"Islam","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"B8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ana.10579","article-title":"Markers of cellular proliferation are expressed in cortical tubers","volume":"53","author":"Lee","year":"2003","journal-title":"Ann Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/08830738050200040901","article-title":"Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment","volume":"20","author":"Curatolo","year":"2005","journal-title":"J Child Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1212\/WNL.0b013e3182768923","article-title":"Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring","volume":"79","author":"Mohamed","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"B11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/epi.12545","article-title":"Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex","volume":"55","author":"Ruppe","year":"2014","journal-title":"Epilepsia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1212\/01.wnl.0000280579.04974.c0","article-title":"Cognitive impairment in tuberous sclerosis complex is a multifactorial condition","volume":"70","author":"Jansen","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"B13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.pediatrneurol.2013.12.002","article-title":"Mechanism-based treatment in tuberous sclerosis complex","volume":"50","author":"J\u00fclich","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"issue":"11","key":"B15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","article-title":"Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex","volume":"76","author":"Numis","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/cercor\/bhs135","article-title":"Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders","volume":"23","author":"Lewis","year":"2013","journal-title":"Cereb Cortex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"issue":"10","key":"B19","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1111\/j.1528-1167.2010.02695.x","article-title":"The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification","volume":"51","author":"Osborne","year":"2010","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.eplepsyres.2013.05.003","article-title":"Epileptic spasms in tuberous sclerosis complex","volume":"106","author":"Hsieh","year":"2013","journal-title":"Epilepsy Res"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpn.2015.12.005","article-title":"Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC","volume":"20","author":"Curatolo","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2147\/NDT.S51789","article-title":"Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options","volume":"10","author":"Wang","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"B23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40265-016-0552-9","article-title":"The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions","volume":"76","author":"Curatolo","year":"2016","journal-title":"Drugs"},{"issue":"10","key":"B24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/B978-0-444-52891-9.00079-8","article-title":"Functional imaging: PET","volume":"111","author":"Kumar","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"Suppl 9","key":"B26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/epi.12458","article-title":"Resecting the epileptogenic tuber: what happens in the long term?","volume":"54","author":"Shahid","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"B27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.eplepsyres.2013.02.016","article-title":"Predictors of seizure freedom after surgical management of tuberous sclerosis complex: a systematic review and meta-analysis","volume":"105","author":"Zhang","year":"2013","journal-title":"Epilepsy Res"},{"issue":"7","key":"B28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0387-7604(01)00290-X","article-title":"Vigabatrin for tuberous sclerosis complex","volume":"23","author":"Curatolo","year":"2001","journal-title":"Brain Dev"},{"issue":"2","key":"B29","doi-asserted-by":"publisher","first-page":"e57445","DOI":"10.1371\/journal.pone.0057445","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/emmm.201303356","article-title":"Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition","volume":"6","author":"Lakhani","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"8","key":"B31","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/j.1528-1167.2007.01178_3.x","article-title":"Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex","volume":"48","author":"J\u00f3zwiak","year":"2007","journal-title":"Epilepsia"},{"issue":"5","key":"B32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"issue":"5","key":"B34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"issue":"10056","key":"B35","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neulet.2011.02.037","article-title":"Therapeutic role of mammalian target of rapamycin (mTOR) in preventing epileptogenesis","volume":"497","author":"McDaniel","year":"2011","journal-title":"Neurosci Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s004390000348","article-title":"Molecular genetic advances in tuberous sclerosis","volume":"107","author":"Cheadle","year":"2000","journal-title":"Hum Genet"},{"issue":"2","key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","article-title":"Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations","volume":"70","author":"Jansen","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"B41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.neuron.2008.09.037","article-title":"Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative\/repetitive behavior","volume":"60","author":"Hoeffer","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"B42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"issue":"10","key":"B44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1101\/lm.027664","article-title":"A recollection of mTOR signaling in learning and memory","volume":"20","author":"Graber","year":"2013","journal-title":"Learn Mem"},{"issue":"Suppl 9","key":"B45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1528-1167.2007.01396.x","article-title":"The basic science of memory as it applies to epilepsy","volume":"48","author":"Meador","year":"2007","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"B46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eplepsyres.2013.03.011","article-title":"Alteration of synaptic plasticity by neonatal seizures in rat somatosensory cortex","volume":"106","author":"Isaeva","year":"2013","journal-title":"Epilepsy Res"},{"issue":"2","key":"B47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nbd.2007.07.015","article-title":"Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex","volume":"28","author":"Zeng","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"12","key":"B48","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1073\/pnas.1222803110","article-title":"Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism","volume":"110","author":"Takeuchi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2013 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2319-4170.110365","article-title":"Mammalian target of rapamycin (mTOR) pathways in neurological diseases","volume":"36","author":"Wong","year":"2013","journal-title":"Biomed J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1212\/WNL.0000000000000922","article-title":"mTOR: its role in the nervous system and involvement in neurologic disease","volume":"83","author":"Child","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"B52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamaneurol.2016.0363","article-title":"Association of mTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism","volume":"73","author":"Mirzaa","year":"2016","journal-title":"JAMA Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijdevneu.2013.02.008","article-title":"A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits","volume":"31","author":"Feliciano","year":"2013","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijdevneu.2013.02.008","article-title":"Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation","volume":"49","author":"Wong","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"B56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/1531-8249(200101)49:167::AID-ANA103.0.CO;2-L","article-title":"Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers","volume":"49","author":"White","year":"2001","journal-title":"Ann Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1038\/ncomms5563","article-title":"Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model","volume":"5","author":"Lozovaya","year":"2014","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers","volume":"63","author":"Talos","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"B59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.21058","article-title":"Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1","volume":"61","author":"Wang","year":"2007","journal-title":"Ann Neurol"},{"issue":"12","key":"B60","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/7010.2006.00242","article-title":"Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex","volume":"21","author":"Valencia","year":"2006","journal-title":"J Child Neurol"},{"issue":"4","key":"B61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.22696","article-title":"Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia","volume":"71","author":"Talos","year":"2012","journal-title":"Ann Neurol"},{"issue":"1","key":"B62","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.nbd.2011.08.015","article-title":"Enhanced GABAergic network and receptor function in pediatric cortical dysplasia type IIB compared with tuberous sclerosis complex","volume":"45","author":"Cepeda","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes","volume":"46","author":"Jansen","year":"2005","journal-title":"Epilepsia"},{"issue":"12","key":"B65","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat Neurosci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnmol.2014.00018","article-title":"Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation","volume":"7","author":"Lasarge","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","article-title":"Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis","volume":"78","author":"Bateup","year":"2013","journal-title":"Neuron"},{"issue":"25","key":"B68","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J Neurosci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1126\/science.1131693","article-title":"Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites","volume":"314","author":"Raab-Graham","year":"2006","journal-title":"Science"},{"issue":"1\u20132","key":"B70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.011","article-title":"A role for the mTOR pathway in surface expression of AMPA receptors","volume":"401","author":"Wang","year":"2006","journal-title":"Neurosci Lett"},{"issue":"2\u20133","key":"B71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eplepsyres.2007.09.009","article-title":"Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons","volume":"77","author":"R\u00fcegg","year":"2007","journal-title":"Epilepsy Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model","volume":"54","author":"Wong","year":"2003","journal-title":"Ann Neurol"},{"issue":"3","key":"B74","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/ana.10648","article-title":"Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat","volume":"53","author":"Zhang","year":"2012","journal-title":"Epilepsia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J Neurosci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","article-title":"Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex","volume":"80","author":"Zhang","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"3","key":"B77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1535-7511.2009.01299.x","article-title":"Infantile spasms: a critical review of emerging animal models","volume":"9","author":"Stafstrom","year":"2009","journal-title":"Epilepsy Curr"},{"issue":"2","key":"B78","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"B79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","author":"Office of Medical Research Applications","year":"1988","journal-title":"Arch Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archderm.141.1.71","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"issue":"1","key":"B82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou","year":"2009","journal-title":"Ann Surg"},{"issue":"8","key":"B84","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","article-title":"Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects","volume":"20","author":"Hsieh","year":"2011","journal-title":"Seizure"},{"issue":"3","key":"B85","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1148\/radiology.195.3.7754001","article-title":"Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain","volume":"195","author":"DiPaolo","year":"1995","journal-title":"Radiology"},{"issue":"10","key":"B86","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp.2006.108134","article-title":"T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning","volume":"78","author":"Hyman","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"B87","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0387-7604(99)00024-8","article-title":"MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice","volume":"21","author":"Rosenbaum","year":"1999","journal-title":"Brain Dev"},{"issue":"4","key":"B88","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jocn.2016.10.048","article-title":"Hippocampal sclerosis and associated focal cortical dysplasia-related epilepsy in neurofibromatosis type I","volume":"37","author":"Gales","year":"2017","journal-title":"J Clin Neurosci"},{"issue":"7","key":"B90","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"B91","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.braindev.2009.12.008","article-title":"Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level","volume":"33","author":"Hachon","year":"2011","journal-title":"Brain Dev"},{"issue":"4","key":"B92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tins.2012.12.002","article-title":"Modeling cognitive dysfunction in neurofibromatosis-1","volume":"36","author":"Diggs-Andrews","year":"2013","journal-title":"Trends Neurosci"},{"issue":"10","key":"B93","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.WNL.0000032370.68306.8A","article-title":"Megalencephaly in NF1: predominantly white matter contribution and mitigation by ADHD","volume":"59","author":"Cutting","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"B95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1528-1157.1993.tb00437.x","article-title":"Patterns of seizures observed in association with neurofibromatosis 1","volume":"34","author":"Korf","year":"1993","journal-title":"Epilepsia"},{"issue":"5","key":"B96","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/08830738030180050501","article-title":"Epilepsy in neurofibromatosis 1","volume":"18","author":"Vivarelli","year":"2003","journal-title":"J Child Neurol"},{"issue":"2","key":"B97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0035-1570020","article-title":"Neurofibromatosis and epilepsy","volume":"5","author":"Caraballo","year":"2016","journal-title":"J Pediatr Epilepsy"},{"issue":"3","key":"B98","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eplepsyres.2013.02.021","article-title":"Epilepsy surgery in neurofibromatosis type 1","volume":"105","author":"Barba","year":"2013","journal-title":"Epilepsy Res"},{"issue":"7","key":"B99","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"24","key":"B100","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat Genet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"issue":"21","key":"B103","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr Biol"},{"issue":"3","key":"B104","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"issue":"6772","key":"B105","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/35002593","article-title":"A neurofibromatosis-1-regulated pathway is required for learning in Drosophila","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"issue":"2","key":"B106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"issue":"22","key":"B107","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"3","key":"B108","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"B109","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/acn3.288","article-title":"A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I","volume":"3","author":"Bearden","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"B110","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"issue":"41","key":"B111","doi-asserted-by":"publisher","first-page":"14087","DOI":"10.1523\/JNEUROSCI.3242-12.2012","article-title":"Neurofibromatosis type 1: modeling CNS dysfunction","volume":"32","author":"Gutmann","year":"2012","journal-title":"J Neurosci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9907-1","article-title":"Sensitization of ion channels contributes to central and peripheral dysfunction in neurofibromatosis type 1","author":"Moutal","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"B113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2478\/v10134-010-0025-8","article-title":"Altered calcium currents and axonal growth in Nf1 haploinsufficient mice","volume":"1","author":"Wang","year":"2010","journal-title":"Transl Neurosci"},{"issue":"11","key":"B114","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in neurofibromatosis type 1","volume":"20","author":"Omrani","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"4","key":"B115","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1152\/jn.01010.2009","article-title":"Augmented sodium currents contribute to the enhanced excitability of small diameter capsaicin-sensitive sensory neurons isolated from Nf1+\/\u2013 mice","volume":"103","author":"Wang","year":"2010","journal-title":"J Neurophysiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-444-62702-5.00011-1","article-title":"Sturge\u2013Weber syndrome","volume":"132","author":"Comi","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"B117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/088307388800300306","article-title":"Prognosis in Sturge\u2013Weber disease: comparison of unihemispheric and bihemispheric involvement","volume":"3","author":"Bebin","year":"1988","journal-title":"J Child Neurol"},{"issue":"1","key":"B118","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/088307389501000113","article-title":"Sturge\u2013Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children","volume":"10","author":"Sujansky","year":"1995","journal-title":"J Child Neurol"},{"issue":"2","key":"B119","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1528-1167.2009.02304.x","article-title":"Medically intractable epilepsy in Sturge\u2013Weber syndrome is associated with cortical malformation: implications for surgical therapy","volume":"51","author":"Maton","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"B120","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1111\/j.1528-1167.2012.03628.x","article-title":"Focal cortical dysplasia type IIa underlying epileptogenesis in patients with epilepsy associated with Sturge\u2013Weber syndrome","volume":"53","author":"Murakami","year":"2012","journal-title":"Epilepsia"},{"issue":"4","key":"B121","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/adc.2005.082578","article-title":"Growth hormone deficiency in Sturge\u2013Weber syndrome","volume":"91","author":"Miller","year":"2006","journal-title":"Arch Dis Child"},{"issue":"1","key":"B122","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2008.03.018","article-title":"Central hypothyroidism and Sturge\u2013Weber syndrome","volume":"39","author":"Comi","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"6","key":"B123","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0883073812451326","article-title":"Sturge\u2013Weber syndrome: clinical spectrum, disease course, and outcome of 30 patients","volume":"28","author":"Jagtap","year":"2013","journal-title":"J Child Neurol"},{"issue":"9","key":"B124","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1111\/j.1528-1167.2009.02072.x","article-title":"An infantile-onset, severe, yet sporadic seizure pattern is common in Sturge\u2013Weber syndrome","volume":"50","author":"Kossoff","year":"2009","journal-title":"Epilepsia"},{"issue":"8","key":"B125","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1586\/14737175.7.8.951","article-title":"Sturge\u2013Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients","volume":"7","author":"Comi","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"B126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.10.015","article-title":"Anticonvulsant efficacy in Sturge\u2013Weber syndrome","volume":"58","author":"Kaplan","year":"2016","journal-title":"Pediatr Neurol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2431-14-96","article-title":"Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature","volume":"14","author":"Rapoport","year":"2014","journal-title":"BMC Pediatr"},{"issue":"2\u20133","key":"B128","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.eplepsyres.2010.09.008","article-title":"A pilot study of the modified Atkins diet for Sturge\u2013Weber syndrome","volume":"92","author":"Kossoff","year":"2010","journal-title":"Epilepsy Res"},{"issue":"1","key":"B129","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3171\/ped.2007.106.1.20","article-title":"Surgical treatment of epilepsy in Sturge\u2013Weber syndrome in children","volume":"106","author":"Bourgeois","year":"2007","journal-title":"J Neurosurg"},{"issue":"2","key":"B130","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge\u2013Weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance","year":"2013","journal-title":"J Child Neurol"},{"issue":"4","key":"B131","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.spen.2015.10.005","article-title":"Current therapeutic options in Sturge\u2013Weber syndrome","volume":"22","author":"Comi","year":"2015","journal-title":"Semin Pediatr Neurol"},{"issue":"21","key":"B132","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge\u2013Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"B133","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/PRS.0000000000001868","article-title":"Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations","volume":"137","author":"Couto","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"B134","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/nen.0b013e31802d9011","article-title":"Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge\u2013Weber syndrome","volume":"66","author":"Comati","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"B135","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/08830738050200070601","article-title":"Sturge\u2013Weber syndrome: altered blood vessel fibronectin expression and morphology","volume":"20","author":"Comi","year":"2005","journal-title":"J Child Neurol"},{"issue":"11","key":"B136","doi-asserted-by":"publisher","first-page":"e80491","DOI":"10.1371\/journal.pone.0080491","article-title":"Mutation of Elfn1 in mice causes seizures and hyperactivity","volume":"8","author":"Dolan","year":"2013","journal-title":"PLoS One"},{"key":"B137","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1038\/ncomms5501","article-title":"Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures","volume":"5","author":"Tomioka","year":"2014","journal-title":"Nat Commun"},{"key":"B138","doi-asserted-by":"publisher","first-page":"370","DOI":"10.12688\/f1000research.7605.1","article-title":"Epileptogenesis in neurocutaneous disorders with focus in Sturge\u2013Weber syndrome","volume":"5","author":"Pinto","year":"2016","journal-title":"F1000Res"},{"issue":"4","key":"B139","doi-asserted-by":"publisher","first-page":"e0152992","DOI":"10.1371\/journal.pone.0152992","article-title":"Analysis of epileptic discharges from implanted subdural electrodes in patients with Sturge\u2013Weber syndrome","volume":"11","author":"Iimura","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"B140","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00003072-200501000-00014","article-title":"Subtraction ictal SPECT co-registered to MRI (SISCOM) in Sturge\u2013Weber syndrome","volume":"30","author":"Namer","year":"2005","journal-title":"Clin Nucl Med"},{"issue":"7","key":"B141","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1528-1167.2011.03066.x","article-title":"Transient focal cortical increase of interictal glucose metabolism in Sturge\u2013Weber syndrome: implications for epileptogenesis","volume":"52","author":"Alkonyi","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"B142","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejpn.2007.02.001","article-title":"Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge\u2013Weber syndrome","volume":"11","author":"Juhasz","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2015.11.009","article-title":"Leveraging a Sturge\u2013Weber gene discovery: an agenda for future research","volume":"58","author":"Comi","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"4","key":"B144","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/lrb.2007.1012","article-title":"Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo","volume":"5","author":"Shirazi","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"960746","DOI":"10.1155\/2015\/960746","article-title":"A potential role for felbamate in TSC- and NF1-related epilepsy: a case report and review of the literature","volume":"2015","author":"Mishal","year":"2015","journal-title":"Case Rep Neurol Med"},{"issue":"5","key":"B146","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.braindev.2008.06.004","article-title":"Neuroimaging findings of Sturge\u2013Weber syndrome in a child with tuberous sclerosis","volume":"31","author":"Curatolo","year":"2009","journal-title":"Brain Dev"},{"issue":"2","key":"B147","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/dmcn.12044","article-title":"Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach","volume":"55","author":"van Eeghen","year":"2013","journal-title":"Dev Med Child Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:49:00Z","timestamp":1498380540000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":147,"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00087","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}